Clinical trial
A Multi-center,_double-blind,_pararel-group Comparison Trial to Investigate the Effect of Short-term Administration of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients (Phase_4 Study)
NCT01439009 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center,_double-blind,_pararel-group Comparison Trial to Investigate the Effect of Short-term Administration of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients (Phase_4 Study)
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- March 31, 2014
- Enrollment
- 100 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.